Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway.

Huang G, Tang B, Tang K, Dong X, Deng J, Liao L, Liao Z, Yang H, He S

DOI: 10.3892/or.2014.3099
Published: 2014 May
Container: Oncology reports
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3892/or.2014.3099,
  title = {Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway.},
  author = {Huang G and Tang B and Tang K and Dong X and Deng J and Liao L and Liao Z and Yang H and He S},
  year = {2014},
  journal = {Oncology reports},
  doi = {10.3892/or.2014.3099},
  url = {https://doi.org/10.3892/or.2014.3099}
}

RIS

TY  - JOUR
TI  - Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway.
AU  - Huang G
AU  - Tang B
AU  - Tang K
AU  - Dong X
AU  - Deng J
AU  - Liao L
AU  - Liao Z
AU  - Yang H
AU  - He S
PY  - 2014
JO  - Oncology reports
DO  - 10.3892/or.2014.3099
UR  - https://doi.org/10.3892/or.2014.3099
ER  -

APA

G, H., B, T., K, T., X, D., J, D., L, L., Z, L., H, Y., & S, H. (2014). Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway.. Oncology reports. https://doi.org/10.3892/or.2014.3099

Source records

pubmed · retrieved 2026-09-24T21:35:47.791Z